Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b

Subunit vaccines require particulate adjuvants to induce the desired immune responses. Pre-clinical manufacturing methods of adjuvants are often batch dependent, which complicates scale-up for large-scale good manufacturing practice (GMP) production. The cationic liposomal adjuvant CAF09b, composed...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Signe Tandrup, Christensen, Dennis, Perrie, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767004/
https://www.ncbi.nlm.nih.gov/pubmed/33352684
http://dx.doi.org/10.3390/pharmaceutics12121237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767004/
https://www.ncbi.nlm.nih.gov/pubmed/33352684
http://dx.doi.org/10.3390/pharmaceutics12121237

Ejemplares similares